Contact Information: Contact: David Carey Lazar Partners 212-867-1768
PDL BioPharma to Present at the Cowen and Company 29th Annual Health Care Conference on March 18, 2009
| Source: PDL BioPharma
INCLINE VILLAGE, NV--(Marketwire - March 9, 2009) - PDL BioPharma, Inc. (PDL) (NASDAQ : PDLI ) today announced that John P. McLaughlin, President & CEO, will
present at the Cowen and Company 29th Annual Health Care Conference in
Boston on Wednesday, March 18, at 8:45am Eastern time.
A live webcast of the presentation will be available through the PDL
website: www.pdl.com. Please connect to this website at least 15 minutes
prior to the live webcast to allow time for any software download that may
be needed to hear the webcast. A replay will be available at www.pdl.com
starting approximately one hour after completion of the webcast.
About PDL BioPharma
PDL BioPharma, Inc. pioneered the humanization of monoclonal antibodies
and, by doing so, enabled the discovery of a new generation of targeted
treatments for cancer and autoimmune diseases. This press release and
further information about PDL BioPharma, Inc. can be found at: www.pdl.com.
NOTE: PDL BioPharma and the PDL BioPharma logo are considered trademarks of
PDL BioPharma, Inc.